A NOVEL CD147 INHIBITOR SP-8356 ATTENUATES PLAQUE PROGRESSION AND STABILIZES VULNERABLE PLAQUE IN APOE-DEFICIENT MICE

被引:1
|
作者
Pahk, K. [1 ,2 ]
Noh, H. [1 ]
Joung, C. [1 ]
Song, H. Y. [1 ]
Kim, S. [2 ]
Kim, W. K. [1 ]
机构
[1] Korea Univ, Coll Med, Inst Inflammat Control, Seoul, South Korea
[2] Korea Univ, Anam Hosp, Dept Nucl Med, Seoul, South Korea
关键词
D O I
10.1016/j.atherosclerosis.2019.06.839
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
EAS19-0026
引用
收藏
页码:E271 / E271
页数:1
相关论文
共 32 条
  • [1] A novel CD147 inhibitor SP-8356 attenuates plaque progression and stabilizes vulnerable plaque in ApoE-deficient mice
    Pahk, K.
    Joung, C.
    Song, H. Y.
    Kim, S.
    Kim, W.
    EUROPEAN HEART JOURNAL, 2019, 40 : 330 - 330
  • [2] A NOVEL CD147 INHIBITOR SP-8356 ATTENUATES PLAQUE PROGRESSION AND STABILIZES VULNERABLE PLAQUE IN APOE-DEFICIENT MICE
    Pahk, K.
    Joung, C.
    Song, H. Y.
    Kim, S.
    Kim, W.
    JOURNAL OF HYPERTENSION, 2019, 37 : E105 - E106
  • [3] SP-8356, a Novel Inhibitor of CD147-Cyclophilin A Interactions, Reduces Plaque Progression and Stabilizes Vulnerable Plaques in apoE-Deficient Mice
    Pahk, Kisoo
    Joung, Chanmin
    Song, Hwa Young
    Kim, Sungeun
    Kim, Won-Ki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (01)
  • [4] A Novel Small Molecule Compound SP-8356 Targeting CD147 Suppresses Plaque Progression and Promotes Plaque Stability in ApoE-Deficient Mice
    Pahk, Kisoo
    Joung, Chanmin
    Kim, Sungeun
    Kim, Won-Ki
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2020, 104
  • [5] A Novel CD147 Inhibitor, SP-8356, Attenuates Pathological Fibrosis in Alkali-Burned Rat Cornea
    Joung, Chanmin
    Noh, Hyojin
    Jung, Jeein
    Song, Hwa Young
    Bae, Hwanse
    Pahk, Kisoo
    Kim, Won-Ki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (08)
  • [6] Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice
    Hara, Tomoya
    Fukuda, Daiju
    Tanaka, Kimie
    Higashikuni, Yasutomi
    Hirata, Yoichiro
    Nishimoto, Sachiko
    Yagi, Shusuke
    Yamada, Hirotsugu
    Soeki, Takeshi
    Wakatsuki, Tetsuzo
    Shimabukuro, Michio
    Sata, Masataka
    ATHEROSCLEROSIS, 2015, 242 (02) : 639 - 646
  • [7] Role of CaMKII in Atherosclerotic Plaque Progression in ApoE-Deficient Mice
    Ebenebe, Obialunanma V.
    Heather, Alison K.
    Erickson, Jeffrey R.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38
  • [8] Rivaroxaban, a direct factor Xa inhibitor, attenuates plaque progression and destabilization in ApoE-deficient mice by inhibiting macrophage activation
    Hara, T.
    Fukuda, D.
    Tanaka, K.
    Higashikuni, Y.
    Hirata, Y.
    Yamada, H.
    Soeki, T.
    Wakatsuki, T.
    Shimabukuro, M.
    Sata, M.
    EUROPEAN HEART JOURNAL, 2014, 35 : 613 - 613
  • [9] Sitagliptin Reduces Plaque Macrophage Content and Stabilizes Arteriosclerotic Lesions in Apoe-Deficient Mice
    Burgmaier, Mathias
    Liberman, Ana
    Vasic, Dusica
    Ostertag, Rahel
    Esser, Melanie
    Walcher, Daniel
    Ludwig, Andreas
    Marx, Nikolaus
    Vittone, Francesca
    CIRCULATION, 2011, 124 (21)
  • [10] A novel CD147 inhibitor, SP-8356, reduces neointimal hyperplasia and arterial stiffness in a rat model of partial carotid artery ligation
    Pahk, Kisoo
    Noh, Hyojin
    Joung, Chanmin
    Jang, Mi
    Song, Hwa Young
    Kim, Kyung Won
    Han, Kihoon
    Hwang, Jong-Ik
    Kim, Sungeun
    Kim, Won-Ki
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (01)